Opus Genetics, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Opus Genetics, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$14.20M	$10.99M
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$38.60M	-$62.07M
Operating income as a percentage of revenue.	-271.9%	-564.7%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$49.59M	-$57.53M
Net income divided by the number of shares outstanding — profit attributable to each share.	$0.00	$-2.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$0.00	$-2.00

Balance Sheet

	2025-12-31	2024-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$45.10M	$30.30M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$50.24M	$36.86M
All of the company's interest-bearing borrowings, short and long term combined.	$1.13M	–
Everything the company owes — debt, unpaid bills, and other obligations.	$34.90M	$11.29M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$15.35M	$6.72M

Cash Flow Statement

	2025-12-31	2024-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$35.25M	-$25.58M